Main Profile


Description in a few words:

Eczacibasi Monrol specializes in producing and selling agents for PET (Positron emission tomography) and SPECT (Single Photon Emission Computed Tomography) scans, which are critical for detecting cancer, heart diseases and brain disorders, among other serious diseases. Eczacıbaşı Monrol also locally produces and sells therapy products like Lutetium Chloride. Main export regions include the EU, MENA, Asia Pacific and South America. The Company also operates FDG production facilities in UAE, Kuwait, Iraq and Pakistan.

Current Leadership:

Aydın Küçük, General Manager

Founding Year:

Sustainability and innovation are two of our core values, and we strive for continuous improvement in our operations and products while trying to serve patients all around the world.


Main product categories or therapies of focus

- Radiopharmaceuticals

. Diagnostic products

. Therapeutic products


R&D focus

- Theranostics

- Cold kits for 99mTc

- 18F derivatives


Export % in revenues:

- Exports 20% of total sales

- Total global sales 45% of total sales

- EU, Middle East, South America, North Africa, Asia-Pacific countries

In More Depth

Number of employees


GMP certificates

- GMP certificate (all facilities)

- EU GMP Certificate (Gebze facility)

- Taiwan FDA GMP Certificate (Gebze facility)

Revenue or Growth Rate in past financial year

- Revenue growth from 2018/2019 – 36%

USP/ or a differentiating fact:

- First company to produce Tc 99m generator and FDG in Turkey

- First company to produce and register Lutetium Chloride in Turkey

- Highest number of FDG production facilities covering all over Turkey

Prominent partnerships/ clients

- IBA, Sumitomo, IRE, ITG